(3084,9542,10718,145957) // 2066v1

Takahashi Y, Fukuda Y, Yoshimura J, Toyoda A, Kurppa K, Moritoyo H, Belzil VV, Dion PA, Higasa K, Doi K, Ishiura H, Mitsui J, Date H, Ahsan B, Matsukawa T, Ichikawa Y, Moritoyo T, Ikoma M, Hashimoto T, Kimura F, Murayama S, Onodera O, Nishizawa M, Yoshida M, Atsuta N, Sobue G, Fifita JA, Williams KL, Blair IP, Nicholson GA, Gonzalez-Perez P, Brown RH Jr, Nomoto M, Elenius K, Rouleau GA, Fujiyama A, Morishita S, Goto J, Tsuji S

ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.

Am J Hum Genet 93:900-5 (2013)
DOI:10.1016/j.ajhg.2013.09.008

Takahashi Y, Uchino A, Shioya A, Sano T, Matsumoto C, Numata-Uematsu Y, Nagano S, Araki T, Murayama S, Saito Y

Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.

Neuropathology 39:268-278 (2019)
DOI:10.1111/neup.12558

Modol-Caballero G, Santos D, Navarro X, Herrando-Grabulosa M

Neuregulin 1 Reduces Motoneuron Cell Death and Promotes Neurite Growth in an in Vitro Model of Motoneuron Degeneration.

Front Cell Neurosci 11:431 (2017)
DOI:10.3389/fncel.2017.00431

Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL

Genetics of amyotrophic lateral sclerosis: A review.

J Neurol Sci 399:217-226 (2019)
DOI:10.1016/j.jns.2019.02.030